A prospective pilotstudy of immunological and radiological effects of intrathecal rituximab in patients with secondary progressive multiple sclerosis

The aim of this study is to investigate the safety of intrathecal administered Rituximab to patients with secondary progressive multiple sclerosis, based upon analysis of the intrathecal and periferal immune response.